GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (FRA:DV3R) » Definitions » Equity-to-Asset

Delcath Systems (FRA:DV3R) Equity-to-Asset : 0.41 (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Delcath Systems Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Delcath Systems's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €14.47 Mil. Delcath Systems's Total Assets for the quarter that ended in Dec. 2023 was €35.41 Mil. Therefore, Delcath Systems's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.41.

The historical rank and industry rank for Delcath Systems's Equity-to-Asset or its related term are showing as below:

FRA:DV3R' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.18   Med: 0.22   Max: 0.76
Current: 0.41

During the past 13 years, the highest Equity to Asset Ratio of Delcath Systems was 0.76. The lowest was -2.18. And the median was 0.22.

FRA:DV3R's Equity-to-Asset is ranked worse than
76.96% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs FRA:DV3R: 0.41

Delcath Systems Equity-to-Asset Historical Data

The historical data trend for Delcath Systems's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delcath Systems Equity-to-Asset Chart

Delcath Systems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.45 0.64 0.36 -0.33 0.41

Delcath Systems Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.33 -0.43 -0.01 0.52 0.41

Competitive Comparison of Delcath Systems's Equity-to-Asset

For the Medical Devices subindustry, Delcath Systems's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delcath Systems's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Delcath Systems's Equity-to-Asset falls into.



Delcath Systems Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Delcath Systems's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=14.468/35.408
=0.41

Delcath Systems's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=14.468/35.408
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Delcath Systems  (FRA:DV3R) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Delcath Systems Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Delcath Systems's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Delcath Systems (FRA:DV3R) Business Description

Traded in Other Exchanges
Address
1633 Broadway, Suite 22C, New York, NY, USA, 10019
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Delcath Systems (FRA:DV3R) Headlines

No Headlines